Healthcare
Schrödinger, Inc.(SDGR)
Live Price
Offline$15.76
+1.48% today
1Y Change
-23.69%
Window
Jun 23, 2025 → Jun 17, 2026
- Market Cap
- $930.00M
- Revenue Growth
- +23.3%
- EPS Growth
- +45.1%
- Dividend Yield
- 0.0%
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Schrödinger, Inc. (SDGR) is a Healthcare stock with a market cap of $930.00M and listed on NASDAQ. The stock last traded around $15.76 and down 23.7% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +23.3%, EPS growth of +45.1%, a dividend yield of 0.0%. What stands out right now is revenue +23.3%, EPS +45.1%, free cash flow +107.6% with operating margin -65.2% and ROIC -30.2%. Valuation is more restrained than many high-expectation growth names at price/sales 3.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SDGR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+23.3% vs +7.6% peer median
Operating Margin
Below sector median
-65.2% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +23.3% and EPS at +45.1%, with operating margin around -65.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Δ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | — | +2.3% | -1.8% | +22.1% |
2026 Feb 25, 2026 | +438.5% | +8.1% | +11.2% | -3.4% |
2025 Nov 5, 2025 | +40.0% | -5.7% | -9.1% | -6.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SDGR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SDGR Max Drawdown
-51.93%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SDGR and SPY.
Company Overview
Schrödinger, Inc.
NASDAQ Global Select
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Leadership
- Ramy Farid
- IPO Date
- Feb 6, 2020
- Employees
- 891
- Street Address
- 1540 Broadway
- Mailing
- New York City, NY, 10036
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 212 295 5800
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 3.6
- Price/Book
- 2.5
Growth
- Revenue
- +23.3%
- EPS
- +45.1%
- Free Cash Flow
- +107.6%
Profitability
- Gross Margin
- 55.7%
- Operating Margin
- -65.2%
- Net Margin
- -40.4%
- ROE
- -29.5%
- ROIC
- -30.2%
Balance Sheet
- Debt/Equity
- 0.30
- Current Ratio
- 2.75
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.